RN

Ritesh Nandkumar Ahuja

Active Director Managing Director DIN 11898209
DIN 11898209 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ritesh Nandkumar Ahuja

Ritesh Nandkumar Ahuja is a Managing Director at Skyroot Pharma Private Limited (since 2026).

DIN 11898209
Primary Designation Managing Director
First Appointment 18 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skyroot Pharma Private Limited U21002MR2026PTC479852
Managing Director18 Aug 20262026Active

Board colleagues of Ritesh Nandkumar Ahuja

NameDINCompanyDesignation
Pooja Dhananjay LalsareSkyroot Pharma Private LimitedIndividual Subscriber
Riddhi Kapil Ahuja11898210Skyroot Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Skyroot Pharma Private Limited
Premium access

Shareholding and investment profile for Ritesh Nandkumar Ahuja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritesh Nandkumar Ahuja

Ritesh Nandkumar Ahuja currently holds 1 directorship: Skyroot Pharma Private Limited (Managing Director, since 18 Aug 2026).

Ritesh Nandkumar Ahuja was first appointed on 18 Aug 2026 as Managing Director at Skyroot Pharma Private Limited.

The current boards of Ritesh Nandkumar Ahuja's companies include Pooja Dhananjay Lalsare (Skyroot Pharma Private Limited), Riddhi Kapil Ahuja (Skyroot Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available